The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation

Journal of Cutaneous Pathology

Volumn 23, Issue 4, 1996, Pages 319-322

  Chimenti, Sergio ^b   Cerroni, Lorenzo ^a   Zenahlik, Paul ^a   Peris, Ketty ^b   Kerl, Helmut ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b University of Graz ^*

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN ANTIBODY;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BASAL CELL CARCINOMA; BENIGN TUMOR; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KERATOSIS; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PSEUDOLYMPHOMA; SKIN BIOPSY;

EID: 0029780241     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01304.x     Document Type: Article

References (22)

1. Rijlaarsdam JU, Meijer CJLM, Willemze R. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphoma: A comparative clinicopathologic study of 57 patients. Cancer 1990: 65: 2301.
2. Poppema S, Hollema H, Visser L, Vos H. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocytes subsets in paraffin-embedded tissue sections. Am J Pathol 1987: 127: 418.
3. Browne G, Tobin B, Carney DN, Dervan PA. Aberrant MT2 positivity distinguishes follicular lymphoma from reactive follicular hyperplasia in B5- and formalin-fixed paraffin sections. Am J Clin Pathol 1991: 96: 90.
4. Utz GL, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: Comparison of MT2 and bcl-2 antibodies. Hum Pathol 1993: 24: 1155.
5. Wood BL, Bacchi MM, Bacchi CE, Kidd P, Gown AM. Immunocytochemical differentiation of reactive hyperplasia from follicular lymphoma using monoclonal antibodies to cell surface and proliferation-related markers. Appl Immunohistochem 1994: 2: 48.
6. Veloso JD, Rezuke WN, Cartun RW, Abernathy EL, Pastuszak WT. Immunohistochemical distinction of follicular lymphoma from follicular hyperplasia in formalin-fixed tissues using monoclonal antibodies MT2 and bcl-2. Appl Immunohistochem 1995: 3: 153.
7. Ng CS, Chan JKC, Hui PK, Lo STH. Monoclonal antibodies reactive with normal and neoplastic T cells in paraffin sections. Hum Pathol 1988: 19: 295.
8. Norton AJ, Rivas C, Isaacson PG. A comparison between monoclonal antibody MT2 and immunoglobulin staining in the differential diagnosis of follicular lymphoid proliferations in routinely fixed wax-embedded biopsies. Am J Pathol 1989: 134: 63.
9. Ngan B-Y, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphomas of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med 1988: 318: 1638.
10. Gaulard P, d'Agay M-F, Peuchmaur M, et al. Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 1992: 140: 1089.
11. Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RR, Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med 1982: 307: 1231.
12. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987: 317: 1185.
13. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990: 137: 225.
14. Korsmeyer SJ. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992: 4: 879.
15. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988: I: 292.
16. Kerl H, Ackerman AB. Inflammatory diseases that simulate lymphomas: Cutaneous pseudolymphomas. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, (eds.): Dermatology in General Medicine, 4th ed. New York: McGraw-Hill Book Co., 1993: 1315.
17. Cerroni L, Smolle J, Soyer HP, Martinez Aparicio A, Kerl H. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: A comparative study. J Am Acad Dermatol 1990: 22: 405.
18. Cerroni L, Volkenandt M, Rieger F, Soyer HP, Kerl H. Bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994: 102: 231.
19. Delia D, Borello MG, Berti E, et al. Clonal immunoglobulin rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B cell lymphomas. Cancer Res 1989: 49: 4901.
20. Wood GS, Ngan BY, Tung R, et al. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol 1989: 135: 13.
21. Volkenandt M, Cerroni L, Rieger E, et al. Analysis of the (14;18) translocation in cutaneous lymphomas using the polymerase chain reaction. J Cutan Pathol 1992: 19: 353.
22. Triscott JA, Ritter JH, Swanson PE, Wick MR. Immunoreactivity for bcl-2 protein in cutaneous lymphomas and lymphoid hyperplasia. J Cutan Pathol 1995: 22: 2.